Josep Clotet

3PUBLICATIONS
8CO-AUTHORS
Molecular targetsGenome structure and regulationCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 21, 2023
CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferation.

Eva Quandt, Núria Masip, Sara Hernández-Ortega

|May 06, 2022
Mad3 modulates the G1 Cdk and acts as a timer in the Start network.

Alexis P Pérez, Marta H Artés, David F Moreno

|Aug 18, 2019
Atypical cyclins: the extended family portrait.

Eva Quandt, Mariana P C Ribeiro, Josep Clotet

Pageof 1